161 related articles for article (PubMed ID: 38590815)
1. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
Yao X; Li Q; Chen Y; Du Z; Huang Y; Zhou Y; Zhang J; Wang W; Zhang L; Xie J; Xu C; Ge Y; Zhou Y
Front Public Health; 2024; 12():1332696. PubMed ID: 38590815
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and genotypes analysis of human papillomavirus infection in Beijing, China.
Wang J; Li H; Zhang J; Wang H; Li Y; Liu Z; Liu H
Virol J; 2024 Jan; 21(1):19. PubMed ID: 38229145
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52.
Wang X; Han S; Li X; Wang X; Wang S; Ma L
Virol J; 2022 Mar; 19(1):37. PubMed ID: 35246180
[TBL] [Abstract][Full Text] [Related]
4. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.
Zhang H; Zhang S
Arch Gynecol Obstet; 2023 Jul; 308(1):35-41. PubMed ID: 35904609
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection.
Chen Z; Lin H; Zheng J; Cai L; Chen Z; Li J; Yu L
BMC Infect Dis; 2022 Nov; 22(1):893. PubMed ID: 36443703
[TBL] [Abstract][Full Text] [Related]
7. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.
Zhang C; Cheng W; Liu Q; Guan Q; Zhang Q
Virol J; 2019 May; 16(1):67. PubMed ID: 31109361
[TBL] [Abstract][Full Text] [Related]
8. HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.
Hao S; Wang C; Liu S; He J; Jiang Y
PLoS One; 2020; 15(3):e0230640. PubMed ID: 32208459
[TBL] [Abstract][Full Text] [Related]
9. HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China.
Yin X; Zhang C; Wu X; Feng J; Xie J; Li Y
BMC Womens Health; 2024 Jan; 24(1):68. PubMed ID: 38267981
[TBL] [Abstract][Full Text] [Related]
10. Prevalent characteristics of human papillomavirus infection in 29,508 women in Jinshan District, Shanghai.
Yu Y; Liu HL; He CF; Wang Y; Fu WJ; Gan GP; Qu HL; Zhou YN; Yao L
Taiwan J Obstet Gynecol; 2022 Nov; 61(6):971-976. PubMed ID: 36428000
[TBL] [Abstract][Full Text] [Related]
11. HPV prevalence and genotype distribution among women in eastern China during the Covid-19 pandemic.
Ma Y; Xia X; Zheng W; Dai Y; Zhuang X
Hum Vaccin Immunother; 2023 Dec; 19(1):2212571. PubMed ID: 37226673
[TBL] [Abstract][Full Text] [Related]
12. [Multi-center cross-sectional study on type-specific human papillomavirus infection among Chinese women].
Zhao Y; Zhao F; Hu S; Chen W; Chen F; Cui J; Liu B; Zhang W; Zhang X; Pan Q; Qiao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1351-6. PubMed ID: 26850387
[TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and genotype distribution of high-risk human papillomavirus in 34 420 cases in Yangzhou city, Jiangsu province, China.
Li Y; Liu X; Han C; Ren C
J Med Virol; 2021 Aug; 93(8):5095-5102. PubMed ID: 33847377
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.
Zhang J; Cheng K; Wang Z
Arch Gynecol Obstet; 2020 Dec; 302(6):1329-1337. PubMed ID: 32914222
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women.
Liu S; Mei B; Ouyang Y; Li C
Virol J; 2023 Dec; 20(1):297. PubMed ID: 38102627
[TBL] [Abstract][Full Text] [Related]
18. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China.
Wang T; Luan L; Deng J; Liu N; Wu Q; Gong T; Zhu J; Zhang Z; Zhang J
Hum Vaccin Immunother; 2023 Aug; 19(2):2241309. PubMed ID: 37519009
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus genotypes and infection among women in Changzhou, China.
Geng Y; Liu L
Hum Vaccin Immunother; 2019; 15(7-8):1884-1888. PubMed ID: 31116690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
